Source: 6PR Mornings
Australian medical bioscientist and clinical immunologist Robert Clancy, an expert in the relationship between infection and the airways, declares “the data is crystal clear, overwhelmingly in support of the fact that ivermectin is of significant benefit when used early in Covid-19 disease.
Despite his understandable reluctance to participate in the inexplicable and ubiquitous politics surrounding these two very safe covid-19 treatments, and his genuine bewilderment at governmental refusal to acknowledge the drugs’ efficacy, the Emeritus Professor was very happy to set the record straight.
The Emeritus Professor quoted ‘incredible meta-analyses, where serious statisticians have put all the studies together and come up with… …an 80% reduction in mortality in people using ivermectin – so conclusive that it was unethical to do further studies involving placebo patients.’
Professor Clancy also clarified that there are several studies on the prophylactic properties of both hydroxychloroquine and ivermectin – a significantly less chance of getting serious covid-19 and dying from it or going to hospital with it.